The global next-generation sequencing market size is anticipated to reach USD 42.25 billion by 2033, growing at a CAGR of 18.0% from 2025 to 2033. The next-generation sequencing (NGS) market is ...

The global next generation sequencing (NGS) market is expected to register a robust CAGR of around 15% over the next five years. This growth is primarily driven by the rising adoption of precision ...

FREMONT, Calif., Nov. 14, 2025 (GLOBE NEWSWIRE) -- Paragon Genomics, Inc., a global leader in target enrichment solutions for next-generation sequencing (NGS), today announced the launch of its new ...

Clear Labs announced its expanded automation platform and collaboration with Labcorp to develop streamlined, oncology-focused NGS workflows, marking its move beyond infectious disease sequencing and ...

Tempus AI TEM has been putting in efforts to solidify its position in the genomics space. In September 2025, the company received FDA 510(k) clearance for its xR IVD to support life sciences drug ...

SOPHiA GENETICS (NASDAQ: SOPH), a global leader in AI-driven precision medicine, and Element Biosciences, Inc., a biology ...

Alok Dadhich, Chief Business Officer of LifeCell Diagnostics, said "LifeCell envisions a future in which preventive healthcare is a way of life. Our mission is to make early and accurate diagnostics ...

Detailed price information for Creative Medical Technology Holdings Inc (CELZ-Q) from The Globe and Mail including charting and trades.

Swiss Rockets, MGI US LLC and Complete Genomics Inc. announced today that they entered into a exclusive license agreement with MGI Tech and Complete ...

In May 2023, the Human Pangenome Reference Consortium (HPRC) released the first draft of the human pangenome reference ...

On Nov 8, Japanese drugmaker Takeda Pharmaceutical Co Ltd launched a partnership with OrigiMed to promote the R&D and ...

OGT, using their specialised expertise in the development of superior hybridisation-based capture technology, ensures that ...